Edition:
India

Coherus Announces Proposed Public Offering Of Common Stock

May 21 (Reuters) - Coherus BioSciences Inc ::COHERUS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.COHERUS BIOSCIENCES INC SAYS COMMENCED UNDERWRITTEN PUBLIC OFFERING OF $75,000,000 OF SHARES OF ITS COMMON STOCK.

1:45am IST

Melinta Therapeutics Announces Proposed Offering Of Common Stock

May 21 (Reuters) - Melinta Therapeutics, Inc. ::MELINTA THERAPEUTICS ANNOUNCES PROPOSED OFFERING OF COMMON STOCK.MELINTA THERAPEUTICS - COMMENCED UNDERWRITTEN PUBLIC OFFERING OF SHARES OF ITS COMMON STOCK TO RAISE AGGREGATE PROCEEDS OF APPROXIMATELY $75 MILLION.MELINTA THERAPEUTICS - INTENDS TO...

1:40am IST

Urogen Pharma Announces Positive Interim Results From Pivotal Phase 3 Olympus Trial Of UGN-101

May 21 (Reuters) - Urogen Pharma Ltd ::UROGEN PHARMA ANNOUNCES POSITIVE INTERIM RESULTS FROM PIVOTAL PHASE 3 OLYMPUS TRIAL OF UGN-101 (MITOGEL™) FOR NON-SURGICAL TREATMENT OF UPPER TRACT UROTHELIAL CANCER (UTUC).UROGEN PHARMA LTD - INTERIM RESULTS SHOWED COMPLETE RESPONSE (CR) RATE OF 59 PERCENT IN...

Monday, 21 May 2018

Oncodesign Announces Interim Results Of Clinical Study With First Radiotracer

May 21 (Reuters) - ONCODESIGN SA ::ANNOUNCED ON FRIDAY PUBLICATION OF ABSTRACT WITH INTERIM RESULTS OF FIRST 12 PATIENTS PARTICIPATING IN CLINICAL STUDY WITH ITS FIRST RADIOTRACER.IN FIRST STAGE OF STUDY, 8 PATIENTS WITH EGFR MUTATIONS RECEIVED INJECTION OF RADIOTRACER.RESULTS SHOWED THAT...

Monday, 21 May 2018

Expansion & New Markets

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.